# US 2020/0347412 A1 · Production of macrocyclic ketones in recombinant hosts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0347412 A1
- Document ID: US20200347412A1
- Status: Published application
- Kind: A1
- Application number: 16/760,710
- Filed: 2018-11-01
- Published: 2020-11-05
- Earliest claimed: 2017-11-01
- Assignees: Takasago International Corporation
- Applicants: Takasago International Corporation
- Inventors: Curt aimé Friis NIELSEN; Jon HEAL; Johannes HAERLE
- Web page: https://patentgrep.com/patent/US20200347412A1

## CPC

- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 9/0008: {acting on the aldehyde or oxo group of donors (1.2)}
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 9/1096: {transferring nitrogenous groups (2.6)}
- C12N 9/88: Lyases (4.)
- C12N 9/93: {Ligases (6)}
- C12N 15/63: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12P 7/26: Ketones
- C12P 7/44: Polycarboxylic acids
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

The invention relates to recombinant microorganisms and methods for producing macrocyclic ketones and macrocyclic ketone precursors.

## Claims

### Claim 1

A recombinant host cell producing one or more macrocyclic ketone precursors and/or one or more macrocyclic ketones, comprising:
(a) a gene encoding a polypeptide capable of synthesizing 3-methyl-2-oxopentanoate from L-isoleucine;
(b) a gene encoding a polypeptide capable of synthesizing (S)-2-methylbutanal from 3-methyl-2-oxopentanoate;
(c) a gene encoding a polypeptide capable of synthesizing (S)-2-methylbutyric acid from (S)-2-methylbutanal;
(d) a gene encoding a polypeptide capable of synthesizing (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid;
(e) a gene encoding a polypeptide capable of synthesizing an anteiso fatty acid from (S)-2-methylbutyryl-CoA;
(f) a gene encoding a polypeptide capable of synthesizing a dicarboxylic acid (DCA) from the anteiso fatty acid or from an iso fatty acid;
(g) a gene encoding a polypeptide capable of synthesizing a CoA activated DCA (DCA-CoA) from the DCA;
(h) a gene encoding a polypeptide having cyclisation activity capable of synthesizing a muscone from the DCA; and/or
(i) a gene encoding a polypeptide having cyclisation activity capable of synthesizing the muscone from the DCA-CoA;
wherein at least one of the genes is a recombinant gene.

### Claim 2 (depends on 1)

The recombinant host cell of claim 1, comprising:
(a) the gene encoding the polypeptide capable of synthesizing 3-methyl-2-oxopentanoate from L-isoleucine;
(b) the gene encoding the polypeptide capable of synthesizing (S)-2-methylbutanal from 3-methyl-2-oxopentanoate;
(c) the gene encoding the polypeptide capable of synthesizing (S)-2-methylbutyric acid from (S)-2-methylbutanal;
(d) the gene encoding the polypeptide capable of synthesizing (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid;
(e) the gene encoding the polypeptide capable of synthesizing the anteiso fatty acid from (S)-2-methylbutyryl-CoA;
(f) the gene encoding the polypeptide capable of synthesizing the DCA from the anteiso fatty acid or from an iso fatty acid; and
(g) the gene encoding the polypeptide capable of synthesizing the DCA-CoA from the DCA;
wherein the recombinant host cell produces the one or more macrocyclic ketone precursors.

### Claim 3 (depends on 1)

The recombinant host cell of claim 1, comprising:
(a) the gene encoding the polypeptide capable of synthesizing 3-methyl-2-oxopentanoate from L-isoleucine;
(b) the gene encoding the polypeptide capable of synthesizing (S)-2-methylbutanal from 3-methyl-2-oxopentanoate;
(c) the gene encoding the polypeptide capable of synthesizing (S)-2-methylbutyric acid from (S)-2-methylbutanal;
(d) the gene encoding the polypeptide capable of synthesizing (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid;
(e) the gene encoding the polypeptide capable of synthesizing the anteiso fatty acid from (S)-2-methylbutyryl-CoA;
(f) the gene encoding the polypeptide capable of synthesizing the DCA from the anteiso fatty acid or from an iso fatty acid;
(g) the gene encoding the polypeptide capable of synthesizing the DCA-CoA from the DCA; and
(h) the gene encoding the polypeptide capable of synthesizing the muscone from the DCA;
wherein the recombinant host cell produces the one or more macrocyclic ketones.

### Claim 4 (depends on 1)

The recombinant host cell of claim 1, comprising:
(a) the gene encoding the polypeptide capable of synthesizing 3-methyl-2-oxopentanoate from L-isoleucine;
(b) the gene encoding the polypeptide capable of synthesizing (S)-2-methylbutanal from 3-methyl-2-oxopentanoate;
(c) the gene encoding the polypeptide capable of synthesizing (S)-2-methylbutyric acid from (S)-2-methylbutanal;
(d) the gene encoding the polypeptide capable of synthesizing (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid;
(e) the gene encoding the polypeptide capable of synthesizing the anteiso fatty acid from (S)-2-methylbutyryl-CoA;
(f) the gene encoding the polypeptide capable of synthesizing the DCA from the anteiso fatty acid or from an iso fatty acid;
(g) the gene encoding the polypeptide capable of synthesizing the DCA-CoA from the DCA; and
(i) the gene encoding the polypeptide capable of synthesizing the muscone from the DCA-CoA;
wherein the recombinant host cell produces the one or more macrocyclic ketones.

### Claim 5 (depends on 1)

The recombinant host cell of claim 1, wherein the recombinant host cell has a deletion in a genetic locus encoding a polypeptide capable of oxidizing one or more muscone precursors.

### Claim 6 (depends on 5)

The recombinant host cell of claim 5, wherein the genetic locus encoding a polypeptide capable of oxidizing one or more muscone precursors comprises a peroxisomal acyl-CoA oxidase (POX1) gene.

### Claim 7 (depends on 1)

The recombinant host cell of claim 1, wherein:
(a) the anteiso fatty acid is 12-methyltetradecanoic acid, 14-methylhexadecanoic acid or 16-methyloctadecanoic acid;
(b) the iso fatty acid is palmitic acid;
(c) the DCA is dodecanedioic acid, n-dodecandioic acid, tetradecanedioic acid, n-tetradecanedioic acid, hexadecanedioic acid, n-hexadecanedioic acid, n-methylhexadecanedioic acid octadecanedioic acid, n-octadecanedioic acid, n-methylhexadecanoic acid or eicosanoic acid; and
(d) the CoA activated DCA is hexadecanedioic acid-CoA, n-hexadecanedioic acid-CoA, n-methylhexadecanedioic acid-CoA octadecanedioic acid-CoA, or n-octadecanedioic acid-CoA.

### Claim 8 (depends on 1)

The recombinant host cell of claim 1, wherein:
(a) the anteiso fatty acid is 12-methyltetradecanoic acid, 14-methylhexadecanoic acid or 16-methyloctadecanoic acid;
(b) the iso fatty acid is palmitic acid;
(c) the DCA is n-methylhexadecanoic acid or n-hexadecanedioic acid; and
(d) the DCA-CoA is n-hexadecanedioic acid-CoA or n-methylhexadecanedioic acid-CoA.

### Claim 9 (depends on 1)

The recombinant host cell of claim 1, wherein the (S)-2-methylbutyric acid has an optical purity of at least 80% ee.

### Claim 10 (depends on 1)

The recombinant host cell of claim 1, wherein:
(a) the polypeptide capable of synthesizing 3-methyl-2-oxopentanoate from L-isoleucine comprises a polypeptide having at least 90% sequence identity to any one of the amino acid sequences of SEQ ID NOs:34 or 35;
(b) the polypeptide capable of synthesizing (S)-2-methylbutanal from 3-methyl-2-oxopentanoate comprises a polypeptide having at least 90% sequence identity to any one of the amino acid sequences of SEQ ID NO:36;
(c) the polypeptide capable of synthesizing (S)-2-methylbutyric acid from (S)-2-methylbutanal comprises a polypeptide having at least 90% sequence identity to any one of the amino acid sequences of SEQ ID NOs:37 or 38;
(d) the polypeptide capable of synthesizing (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid comprises a polypeptide having at least 65% sequence identity to any one of the amino acid sequences of SEQ ID NOs:23 or 24;
(e) the polypeptide capable of synthesizing the anteiso fatty acid from (S)-2-methylbutyryl-CoA comprises a polypeptide having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs:25, 26, 27, 28, 29, 30, 31, or 32;
(f) the polypeptide capable of synthesizing the DCA from the anteiso fatty acid or from the iso fatty acid comprises a polypeptide having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs: 21, 22, 41, 42, 43, 44, 45, or 46;
(g) the polypeptide capable of synthesizing the DCA-CoA from the DCA comprises a polypeptide having at least 85% sequence identity to the amino acid sequence of SEQ ID NO:33;
(h) the polypeptide capable of synthesizing the muscone from the CoA activated DCA; and
(i) the polypeptide capable of synthesizing the muscone from the DCA.

### Claim 11 (depends on 1)

The recombinant host cell of claim 1, wherein the one or more macrocyclic ketone precursor is 12-methyltetradecanoic acid, (S)-12-methyltetradecanoic acid, 14-methylhexadecanoic acid, (S)-14-methylhexadecanoate, 16-methyloctadecanoic acid, (S)-16-methyloctadecanoic acid, dodecanedioic acid (dodecane-1,12-dioic acid), (E)-2-dodecenedioic acid, n-dodecenedioic acid, 3-dodecenedioic acid (double bond undefined), tetradecanedioic acid (tetradecane-1,14-dioic acid), 5-tetradecenedioic acid, (5Z)-, n-tetradecanedioic acid, hexadecanedioic acid (hexadecane-1,16-dioic acid), 7-hexadecenedioic acid, (7Z)-n-hexadecenedioic acid, octadecanedioic acid (octadecane-1,18-dioic acid), 9-octadecenedioic acid, (9Z)-, n-octadecenedioic acid, eicosanedioic acid, eicosanoic acid, 9-eicosenedioic acid, (9Z)-, hexadecanedioyl-coenzyme A, cis-9-hexadecenedioyl-CoA, ocadecanedioyl-coenzyme A, cis-9-octadecenedioyl-CoA, hexadecanedioic acid-CoA, n-hexadecenedioic acid-CoA, octadecanedioic acid-CoA, (S)-2-methylbutanoyl-CoA, (R)-3-methyldodecane-1,12-dioic acid, (R)-3-methyldodecane-1,12-dioyl-CoA, (R)-10-methyldodecane-1,12-dioyl-CoA, (R)-3-methyltetradecane-1,14-dioic acid, (R)-(+)-3-methylhexadecanoic acid, (R)-3-methyltetradecane-1,14-dioyl-CoA, (R)-12-methyltetradecane-1,14-dioyl-CoA, (R)-3-methylhexadecane-1,16-dioic acid, (R)-3-methylhexadecane-1,16-dioyl-CoA, (R)-14-methyldexadecane-1,16-dioyl-CoA, (R)-3-methyloctadecane-1,18-dioyl-CoA, (R)-16-methyloctadecane-1,18-dioyl-CoA, (S)-2-methylbutyryl CoA, 3-methylhexadecandioic acid, 3-methylhexadecanedioic acid-CoA, or n-octadecenedioic acid-CoA.

### Claim 12 (depends on 1)

The recombinant host cell of claim 1, wherein the one or more macrocyclic ketone is l-muscone, nor-muscone, or civetone.

### Claim 13 (depends on 1)

The recombinant host cell of claim 1, wherein the recombinant host cell is a plant cell, a mammalian cell, an insect cell, a fungal cell, an algal cell, an archaeal cell, or a bacterial cell.

### Claim 14 (depends on 1)

A method of producing a one or more macrocyclic ketone precursors and/or a one or more macrocyclic ketones a dicarboxylic acid (DCA), a CoA activated DCA (DCA-CoA), an anteiso fatty acid, or a combination thereof in a cell culture, comprising culturing the
recombinant host cell of claim 1 in the cell culture, under conditions in which the genes are expressed; wherein the one or more macrocyclic ketone precursors and/or the one or more macrocyclic ketones, the DCA, the DCA-CoA, the anteiso fatty acid, or the combination thereof is produced by the recombinant host cell.

### Claim 15 (depends on 14)

The method of claim 14, wherein the genes are constitutively expressed and/or expression of the genes is induced.

### Claim 16 (depends on 14)

The method of claim 14, wherein the recombinant host cell is grown in a fermentor at a temperature for a period of time, wherein the temperature and period of time facilitate the production of the one or more macrocyclic ketone precursors and/or the one or more macrocyclic ketones thereof, the DCA, the DCA-CoA, the anteiso fatty acid, or the combination thereof.

### Claim 17 (depends on 1)

A method of producing a one or more macrocyclic ketone precursors and/or a one or more macrocyclic ketones, a dicarboxylic acid (DCA), a CoA activated DCA (DCA-CoA), an anteiso fatty acid, or a combination thereof, comprising whole cell bioconversion of a plant-derived or synthetic L-isoleucine, (S)-2-methylbutyric acid, 3-methyl-2-oxopentanoate, (S)-2-methylbutanal, (S)-2-methylbutyric acid, (S)-2-methylbutyryl-CoA, an anteiso fatty acid, an iso fatty acid, a DCA, or a DCA-CoA in a cell culture of a recombinant host cell of claim 1 using:
(a) a polypeptide capable of synthesizing 3-methyl-2-oxopentanoate from L-isoleucine, comprising a polypeptide having at least 90% sequence identity to any one of the amino acid sequences of SEQ ID NOs:34 or 35;
(b) a polypeptide capable of synthesizing (S)-2-methylbutanal from 3-methyl-2-oxopentanoate, comprising a polypeptide having at least 90% sequence identity to any one of the amino acid sequences of SEQ ID NO:36;
(c) a polypeptide capable of synthesizing (S)-2-methylbutyric acid from (S)-2-methylbutanal, comprising a polypeptide having at least 95% sequence identity to any one of the amino acid sequences of SEQ ID NO:37 or 38;
(d) a polypeptide capable of synthesizing (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid, comprising a polypeptide having at least 65% sequence identity to any one of the amino acid sequences of SEQ ID NOs:23 or 24;
(e) a polypeptide capable of synthesizing the anteiso fatty acid from (S)-2-methylbutyryl-CoA, comprising a polypeptide having at least 60% sequence identity to any one of the amino acid sequence of SEQ ID NOs:25, 26, 27, 28, 29, 30, 31, or 32;
(f) a polypeptide capable of synthesizing the DCA from the anteiso fatty acid or from the iso fatty acid, comprising a polypeptide having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs: 21, 22, 41, 42, 43, 44, 45, or 46;
(g) a polypeptide capable of synthesizing the DCA-CoA from the DCA, comprising a polypeptide having at least 85% sequence identity to the amino acid sequence of SEQ ID NO:33; and
(h) the polypeptide capable of synthesizing the muscone from the DCA; wherein at least one of the polypeptides is a recombinant polypeptide.

### Claim 18 (depends on 17)

The method of claim 17, wherein the one or more macrocyclic ketone precursors and/or the one or more macrocyclic ketones, the DCA, the DCA-CoA, the anteiso fatty acid, or the combination thereof is produced in a permeabilized recombinant host cell that has been transformed with:
(a) a gene encoding the polypeptide capable of synthesizing 3-methyl-2-oxopentanoate from L-isoleucine;
wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to any one of the amino acid sequences of SEQ ID NOs:34 or 35;
(b) a gene encoding the polypeptide capable of synthesizing (S)-2-methylbutanal from 3-methyl-2-oxopentanoate;
wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:36;
(c) a gene encoding the polypeptide capable of synthesizing 2-methylbutyric acid from (S)-2-methylbutanal;
wherein the polypeptide comprises a polypeptide having at least 95% sequence identity to any one of the amino acid sequences of SEQ ID NOs:37 or 38;
(d) a gene encoding the polypeptide capable of synthesizing (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid;
wherein the polypeptide comprises a polypeptide having at least 65% sequence identity to any one of the amino acid sequences of SEQ ID NOs:23 or 24;
(e) a gene encoding the polypeptide capable of synthesizing the anteiso fatty acid from (S)-2-methylbutyryl-CoA;
wherein the polypeptide comprises a polypeptide having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs:25, 26, 27, 28, 29, 30, 31, or 32;
(f) a gene encoding the polypeptide capable of synthesizing the DCA from the anteiso fatty acid or from the iso fatty acid;
wherein the polypeptide comprises a polypeptide having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs: 21, 22, 41, 42, 43, 44, 45, or 46;
(g) a gene encoding the polypeptide capable of synthesizing the DCA-CoA from the DCA;
wherein the polypeptide comprises a polypeptide having at least 85% sequence identity to the amino acid sequence of SEQ ID NO:33; (h) a gene encoding the polypeptide capable of synthesizing the muscone from the DCA-CoA; and/or
(i) a gene encoding the polypeptide capable of synthesizing the muscone from the DCA.

### Claim 19 (depends on 14)

The method of claim 14, wherein the cell culture comprises:
(a) the macrocyclic ketone, the one or more macrocyclic ketone precursors thereof, the DCA, the DCA-CoA, the anteiso fatty acid, or the combination thereof produced by the recombinant host cell or whole cell bioconversion of the plant-derived or synthetic L-isoleucine, (S)-2-methylbutyric acid, 3-methyl-2-oxopentanoate, (S)-2-methylbutanal, (S)-2-methylbutyric acid, (S)-2-methylbutyryl-CoA, an anteiso fatty acid, an iso fatty acid, a DCA, or a DCA-CoA; and
(b) supplemental nutrients comprising trace metals, vitamins, salts, yeast nitrogen base (YNB), and/or amino acids.

### Claim 20 (depends on 17)

The method of claim 17, wherein the (S)-2-methylbutyric acid has an optical purity of at least 80% ee.

### Claim 21 (depends on 14)

The method of claim 14, further comprising isolating the one or more macrocyclic ketone precursors and/or the one or more macrocyclic ketones thereof, the DCA, the DCA-CoA, the anteiso fatty acid, or a combination thereof.

### Claim 22 (depends on 21)

The method of claim 21, wherein the isolating step comprises separating a liquid phase of the cell culture from a solid phase of the cell culture to obtain a supernatant comprising the produced macrocyclic ketone, the one or more macrocyclic ketone precursors, the DCA, the DCA-CoA, or the anteiso fatty acid, and:
(a) contacting the supernatant with one or more adsorbent resins in order to obtain at least a portion of the produced macrocyclic ketone, the one or more macrocyclic ketone precursors, the DCA, the DCA-CoA, or the anteiso fatty acid; or
(b) contacting the supernatant with one or more ion exchange or reverse-phase chromatography columns in order to obtain at least a portion of the produced macrocyclic ketone, the one or more macrocyclic ketone precursors, the DCA, the DCA-CoA, or the anteiso fatty acid; or
(c) crystallizing or extracting the produced macrocyclic ketone, the one or more macrocyclic ketone precursors, the DCA, the DCA-CoA, or the anteiso fatty acid;
thereby isolating the produced macrocyclic ketone, the one or more macrocyclic ketone precursors, the DCA, the DCA-CoA, or the anteiso fatty acid.

### Claim 23 (depends on 14)

The method of claim 14, further comprising recovering the macrocyclic ketone, the one or more macrocyclic precursors thereof, the DCA, the DCA-CoA, the anteiso fatty acid alone, or a composition thereof from the cell culture.

### Claim 24

An in vitro method for producing a one or more macrocyclic ketone precursors and/or a one or more macrocyclic ketones a dicarboxylic acid (DCA), a CoA activated DCA (DCA-CoA), an anteiso fatty acid, or a combination thereof, comprising adding:
(a) a polypeptide capable of synthesizing 3-methyl-2-oxopentanoate from L-isoleucine and having at least 90% sequence identity to any one of the amino acid sequences of SEQ ID NOs:34 or 35;
(b) a polypeptide capable of synthesizing (S)-2-methylbutanal from 3-methyl-2-oxopentanoate and having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:36;
(c) a polypeptide capable of synthesizing 2-methylbutyric acid from (S)-2-methylbutanal and having at least 95% sequence identity to any one of the amino acid sequences of SEQ ID NOs:37 or 38;
(d) a polypeptide capable of synthesizing (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid and having at least 65% sequence identity to any one of the amino acid sequences of SEQ ID NOs:23 or 24;
(e) a polypeptide capable of synthesizing the anteiso fatty acid from (S)-2-methylbutyryl-CoA and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs:25, 26, 27, 28, 29, 30, 31, or 32;
(f) a polypeptide capable of synthesizing the DCA from the anteiso fatty acid or from the iso fatty acid and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs: 21, 22, 41, 42, 43, 44, 45, or 46;
(g) a polypeptide capable of synthesizing the DCA-CoA from the DCA and having at least 85% sequence identity to the amino acid sequence of SEQ ID NO:33;
(h) a polypeptide capable of synthesizing the muscone from the CoA activated DCA; and/or
(i) a polypeptide capable of synthesizing the muscone from DCA;
and a plant-derived or synthetic L-isoleucine, (S)-2-methylbutyric acid, 3-methyl-2-oxopentanoate, (S)-2-methylbutanal, (S)-2-methylbutyric acid, (S)-2-methylbutyryl-CoA, an anteiso fatty acid, an iso fatty acid, a DCA or a DCA-CoA to a reaction mixture;
wherein at least one of the polypeptides is a recombinant polypeptide; and synthesizing the one or more macrocyclic ketone precursors and/or the one or more macrocyclic ketones, the DCA, the DCA-CoA, the anteiso fatty acid, or the combination thereof.

### Claim 25 (depends on 24)

The method of claim 24, wherein the reaction mixture comprises:
(a) the polypeptide capable of synthesizing the DCA from the anteiso fatty acid or from the iso fatty acid and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs: 21, 22, 41, 42, 43, 44, 45, and 46; and
(b) the polypeptide capable of synthesizing the DCA-CoA from the DCA and having at least 85% sequence identity to the amino acid sequence of SEQ ID NO:33; and
wherein at least one of the polypeptides is a recombinant polypeptide; and synthesizing the one or more macrocyclic ketone precursors and/or the one or more macrocyclic ketones, the DCA, the DCA-CoA, the anteiso fatty acid, or the combination thereof.

### Claim 26 (depends on 14)

The method of claim 14, wherein the one or more macrocyclic ketone is l-muscone, nor-muscone, or civetone.

### Claim 27 (depends on 14)

The method of claim 14, wherein:
(a) the one or more precursors include 12-methyltetradecanoic acid, (S)-12-methyltetradecanoic acid, 14-methylhexadecanoic acid, (S)-14-methylhexadecanoate, 16-methyloctadecanoic acid, (S)-16-methyloctadecanoic acid, dodecanedioic acid (dodecane-1,12-dioic acid), (E)-2-dodecenedioic acid, n-dodecenedioic acid, 3-dodecenedioic acid (double bond undefined), tetradecanedioic acid (tetradecane-1,14-dioic acid), 5-tetradecenedioic acid, (5Z)-, n-tetradecanedioic acid, hexadecanedioic acid (hexadecane-1,16-dioic acid), 7-hexadecenedioic acid, (7Z)-n-hexadecenedioic acid, octadecanedioic acid (octadecane-1,18-dioic acid), 9-octadecenedioic acid, (9Z)-, n-octadecenedioic acid, eicosanedioic acid, eicosanoic acid, 9-eicosenedioic acid, (9Z)-, hexadecanedioyl-coenzyme A, cis-9-hexadecenedioyl-CoA, ocadecanedioyl-coenzyme A, cis-9-octadecenedioyl-CoA, hexadecanedioic acid-CoA, n-hexadecenedioic acid-CoA, octadecanedioic acid-CoA, n-methylhexadecanoic acid, n-methylhexadecanoic acid-CoA, (S)-2-methylbutanoyl-CoA, (R)-3-methyldodecane-1,12-dioic acid, (R)-3-methyldodecane-1,12-dioyl-CoA, (R)-10-methyldodecane-1,12-dioyl-CoA, (R)-+-3-methylhexadecanoic acid, (R)-3-methyltetradecane-1,14-dioic acid, (R)-3-methyltetradecane-1,14-dioyl-CoA, (R)-12-methyltetradecane-1,14-dioyl-CoA, (R)-3-methylhexadecane-1,16-dioic acid, (R)-3-methylhexadecane-1,16-dioyl-CoA, (R)-14-methyldexadecane-1,16-dioyl-CoA, (R)-3-methyloctadecane-1,18-dioyl-CoA, (R)-16-methyloctadecane-1,18-dioyl-CoA, (S)-2-methylbutyryl CoA, 3-methylhexadecandioic acid, 3-methylhexadecanedioic acid-CoA, or n-octadecenedioic acid-CoA;
(b) the anteiso fatty acid is 12-methyltetradecanoic acid, 14-methylhexadecanoic acid, or 16-methyloctadecanoic acid;
(c) the iso fatty acid is palmitic acid;
(d) the DCA is dodecandioic acid, n-dodecandioic acid, tetradecanedioic acid, n-tetradecanedioic acid, hexadecanedioic acid, n-methylhexadecanoic acid, n-hexadecanedioic acid, octadecanedioic acid, n-octadecanedioic acid, or eicosanoic acid; and
(e) the DCA-CoA is hexadecanedioic acid-CoA, n-methylhexadecanedioic acid-CoA n-hexadecanedioic acid-CoA, octadecanedioic acid-CoA, or n-octadecanedioic acid-CoA.

### Claim 28 (depends on 27)

The method of claim 27, wherein:
(a) the anteiso fatty acid is 12-methyltetradecanoic acid, 14-methylhexadecanoic acid, or 16-methyloctadecanoic acid;
(b) the iso fatty acid is palmitic acid;
(c) the DCA is n-methylhexadecanoic acid or n-hexadecanedioic acid; and
(d) the DCA-CoA is n-methylhexadecanoic acid-CoA or n-hexadecanedioic acid-CoA.

### Claim 29 (depends on 14)

The method of claim 14, wherein the recombinant host cell or the whole cell comprises a plant cell, a mammalian cell, an insect cell, a fungal cell, an algal cell, an archaeal cell, or a bacterial cell.

### Claim 30 (depends on 1)

A cell culture, comprising the recombinant host cell of claim 1, the cell culture further comprising:
(a) the one or more macrocyclic ketone precursors and/or the one or more macrocyclic ketones, the DCA, the DCA-CoA, the anteiso fatty acid, or the combination thereof produced by the recombinant host cell; and
(b) supplemental nutrients comprising trace metals, vitamins, salts, yeast nitrogen base (YNB), and/or amino acids;
wherein the one or more macrocyclic ketone precursors and/or one or more macrocyclic ketones, the DCA, the DCA-CoA, the anteiso fatty acid, or the combination thereof are present at a concentration of at least 1 mg/liter of the cell culture.

### Claim 31 (depends on 1)

A cell culture lysate from the recombinant host cell of claim 1, grown in the cell culture, comprising:
(a) the one or more macrocyclic ketone precursors and/or the one or more macrocyclic ketones, the DCA, the DCA-CoA, the anteiso fatty acid, or the combination thereof produced by the recombinant host cell; and
(b) supplemental nutrients comprising trace metals, vitamins, salts, yeast nitrogen base (YNB), and/or amino acids;
wherein the one or more macrocyclic ketone precursors and/or the one or more macrocyclic ketones, the DCA, the DCA-CoA, the anteiso fatty acid, or the combination thereof are present at a concentration of at least 1 mg/liter of the cell culture.

### Claim 32

A nucleic acid molecule encoding:
(a) a polypeptide capable of synthesizing 3-methyl-2-oxopentanoate from L-isoleucine and having at least 90% sequence identity to any one of the amino acid sequences of SEQ ID NOs:34 or 35;
(b) a polypeptide capable of synthesizing (S)-2-methylbutanal from 3-methyl-2-oxopentanoate and having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:36;
(c) a polypeptide capable of synthesizing (S)-2-methylbutyric acid from (S)-2-methylbutanal and having at least 95% sequence identity to any one of the amino acid sequences of SEQ ID NOs:37 or 38;
(d) a polypeptide capable of synthesizing (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid and having at least 65% sequence identity to the amino acid sequence of SEQ ID NOs:23 or 24;
(e) a polypeptide capable of synthesizing an anteiso fatty acid from (S)-2-methylbutyryl-CoA and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs:25, 26, 27, 28, 29, 30, 31, or 32;
(f) a polypeptide capable of synthesizing a DCA from the anteiso fatty acid or from an iso fatty acid and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs: 21, 22, 41, 42, 43, 44, 45, or 46;
(g) a polypeptide capable of synthesizing a DCA-CoA from the DCA and having at least 85% sequence identity to the amino acid sequence of SEQ ID NO:33;
(h) a polypeptide capable of synthesizing a muscone from the DCA; and/or
(i) a polypeptide capable of synthesizing a muscone from the DCA-CoA.

### Claim 33 (depends on 32)

The nucleic acid molecule of claim 32, wherein the nucleic acid molecule is cDNA.

### Claim 34

A purified polypeptide or a catalytically active portion thereof capable of producing:
(a) 3-methyl-2-oxopentanoate from L-isoleucine and having at least 90% sequence identity to any one of the amino acid sequences of SEQ ID NOs:34 or 35;
(b) (S)-2-methylbutanal from 3-methyl-2-oxopentanoate and having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:36;
(c) 2-methylbutyric acid from (S)-2-methylbutanal and having at least 95% sequence identity to any one of the amino acid sequences of SEQ ID NOs:37 or 38;
(d) (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid and having at least 65% sequence identity to any one of the amino acid sequences of SEQ ID NOs:23 or 24;
(e) an anteiso fatty acid from (S)-2-methylbutyryl-CoA and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs:25, 26, 27, 28, 29, 30, 31, or 32;
(f) a DCA from the anteiso fatty acid or from the iso fatty acid and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs:21, 22, 41, 42, 43, 44, 45, and 46;
(g) a DCA-CoA from the DCA and having at least 85% sequence identity to the amino acid sequence of SEQ ID NO:33;
(h) a muscone from the DCA-CoA; and/or
(i) the muscone from the DCA.

### Claim 35 (depends on 1)

A composition comprising the macrocyclic ketone, the one or more macrocyclic ketone precursors, the DCA, the DCA-CoA, the anteiso fatty acid, or the combination thereof produced by the recombinant host cell of claim 1.
